FI956029A0 - Androstaanisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät - Google Patents

Androstaanisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät

Info

Publication number
FI956029A0
FI956029A0 FI956029A FI956029A FI956029A0 FI 956029 A0 FI956029 A0 FI 956029A0 FI 956029 A FI956029 A FI 956029A FI 956029 A FI956029 A FI 956029A FI 956029 A0 FI956029 A0 FI 956029A0
Authority
FI
Finland
Prior art keywords
pharmaceutical compositions
methods
steroids
hypothalamic function
semiochemical
Prior art date
Application number
FI956029A
Other languages
English (en)
Swedish (sv)
Other versions
FI956029A (fi
Inventor
David L Berliner
Nathan William Adams
Clive L Jenningswhite
Original Assignee
Pherin Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pherin Corp filed Critical Pherin Corp
Publication of FI956029A0 publication Critical patent/FI956029A0/fi
Publication of FI956029A publication Critical patent/FI956029A/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/26—Androgens
FI956029A 1993-06-15 1995-12-14 Androstaanisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät FI956029A (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7735993A 1993-06-15 1993-06-15
PCT/US1993/009349 WO1994028904A1 (en) 1993-06-15 1993-09-28 Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods

Publications (2)

Publication Number Publication Date
FI956029A0 true FI956029A0 (fi) 1995-12-14
FI956029A FI956029A (fi) 1996-02-14

Family

ID=22137596

Family Applications (1)

Application Number Title Priority Date Filing Date
FI956029A FI956029A (fi) 1993-06-15 1995-12-14 Androstaanisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät

Country Status (14)

Country Link
EP (2) EP1340502A3 (fi)
JP (1) JP3705806B2 (fi)
AT (1) ATE255898T1 (fi)
BG (1) BG63452B1 (fi)
BR (1) BR9307867A (fi)
CA (1) CA2165325A1 (fi)
DE (1) DE69333352T2 (fi)
ES (1) ES2210243T3 (fi)
FI (1) FI956029A (fi)
HU (1) HUT74172A (fi)
NO (1) NO309926B1 (fi)
NZ (1) NZ257218A (fi)
PL (1) PL183582B1 (fi)
WO (1) WO1994028904A1 (fi)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5883087A (en) * 1991-01-07 1999-03-16 Pherin Corporation Androstane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
US5563131A (en) * 1994-08-04 1996-10-08 Pherin Corporation Pregnane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
US6066627A (en) * 1994-08-04 2000-05-23 Pherin Corporation Steroids as neurochemical initiators of change in human blood levels of LH
US5994333A (en) * 1994-08-04 1999-11-30 Pherin Corporation Pregnane and cholane steroids as neurochemical initiators of change in human hypothalamic function and related pharmaceutical compositions and methods
ATE286123T1 (de) * 1995-10-19 2005-01-15 Univ Columbia Klonierung von pheromon rezeptoren aus vertebraten und deren verwendungen
US5922699A (en) * 1996-06-07 1999-07-13 Pherin Corporation 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
AU726625B2 (en) * 1996-07-23 2000-11-16 Pherin Pharmaceuticals, Inc. Steroids as neurochemical stimulators of the VNO to alleviate symptoms of PMS and anxiety
US6093389A (en) * 1997-12-01 2000-07-25 American Cyanamid Company Methods and compositions for attracting and controlling termites
US6544971B1 (en) * 2000-02-04 2003-04-08 Pherin Pharmaceuticals, Inc. Method of increasing alertness by administration of a vomeropherin, and vomeropherin-emitting alarm devices
US6919337B2 (en) 2000-04-07 2005-07-19 Novartis, Ag 8-Quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
US7019136B2 (en) 2000-04-07 2006-03-28 Novartis, Ag 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as PDE 5 inhibitors
CN1235543C (zh) * 2000-07-05 2006-01-11 松下电器产业株式会社 嗅觉粘膜刺激化合物筛选仪器及测量电极组
AU2013371025B2 (en) * 2012-12-28 2018-01-18 Pherin Pharmaceuticals, Inc. Use of pregn-4-en-20-yn-3-one for the treatment of depressive disorders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB765509A (en) * 1954-02-04 1957-01-09 Pfizer & Co C Improvements in or relating to steroids and the preparation thereof
FR7725M (fi) * 1967-06-22 1970-03-02
GB1267514A (en) * 1968-07-23 1972-03-22 Nat Res Dev Improvements relating to artificial insemination of pigs
DE2345376A1 (de) * 1973-09-06 1975-03-20 Schering Ag Pharmazeutische zubereitung ii
GB1550343A (en) * 1975-07-16 1979-08-15 Gist Brocades Nv Androstane derivatives
DE2758549A1 (de) * 1977-12-23 1979-07-05 Schering Ag Pharmazeutische zubereitung
US5155045A (en) * 1985-01-25 1992-10-13 Trustees Of The University Of Penn. Use of male essence to alter female endocrine response
DD251077A1 (de) * 1986-07-21 1987-11-04 Adw Ddr Mittel zur anregung der brunstreaktion bei schweinen
US5232917A (en) * 1987-08-25 1993-08-03 University Of Southern California Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series
US5208227A (en) * 1987-08-25 1993-05-04 University Of Southern California Method, compositions, and compounds for modulating brain excitability
FR2622194B1 (fr) * 1987-10-27 1990-03-23 Theramex Laboratoire Nouveaux derives de la 19-nor progesterone, leur procede d'obtention et les compositions pharmaceutiques en contenant
US5969168A (en) * 1991-01-07 1999-10-19 Pherin Corporation Androstanes for inducing hypothalamic effects
CA2425841C (en) * 1991-11-22 2006-01-10 Alcon Laboratories, Inc. Angiostatic steroids
US5272134A (en) * 1992-03-24 1993-12-21 Erox Corporation Fragrance compositions and other compositions which contain human pheromones

Also Published As

Publication number Publication date
AU691474B2 (en) 1998-05-21
AU5350494A (en) 1995-01-03
CA2165325A1 (en) 1994-12-22
EP0711169B1 (en) 2003-12-10
NO309926B1 (no) 2001-04-23
ATE255898T1 (de) 2003-12-15
DE69333352D1 (de) 2004-01-22
EP1340502A2 (en) 2003-09-03
WO1994028904A1 (en) 1994-12-22
EP0711169A4 (en) 2000-05-31
HUT74172A (en) 1996-11-28
NO955085L (no) 1996-02-14
BG100286A (bg) 1997-02-28
ES2210243T3 (es) 2004-07-01
NO955085D0 (no) 1995-12-14
HU9503578D0 (en) 1996-02-28
PL183582B1 (pl) 2002-06-28
DE69333352T2 (de) 2004-07-22
BR9307867A (pt) 1996-07-30
JPH09501409A (ja) 1997-02-10
PL312279A1 (en) 1996-04-15
EP1340502A3 (en) 2004-01-21
FI956029A (fi) 1996-02-14
JP3705806B2 (ja) 2005-10-12
BG63452B1 (bg) 2002-02-28
EP0711169A1 (en) 1996-05-15
NZ257218A (en) 1998-07-28

Similar Documents

Publication Publication Date Title
CA2223397A1 (en) Novel nor-pregnanes for inducing hypothalamic effects
FI956029A0 (fi) Androstaanisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät
CA2258177A1 (en) 19-nor-cholane steroids as neurochemical initiators of change in human hypothalamic function
FI956028A0 (fi) Estreenisteroidit ihmisen hypotalaamisen toiminnan muuttamisen neurokemiallisina initiaattoreina sekä tähän liittyvät farmaseuttiset koostumukset ja menetelmät
AU3963797A (en) Steroids as neurochemical stimulators of the vno to alleviate symptoms of pms and anxiety
MX9702253A (es) Nuevos estrenos para inducir efectos hipotalamicos
MX9700881A (es) Pregnanos y colanos como indicadores neuroquimicos del cambio en la funcion hipotalamica.
MXPA94000705A (es) Esteroides de estreno como iniciadores neuroquimicos del cambio en la funcion hipotalamica humana ycomposiciones farmaceuticas y metodos relacionados.
BR9816142A (pt) Esteróides de 19-nor-colano como iniciadores neuroquìmicos de mudança na função hipotalâmica humana
ATE157670T1 (de) Digitoxigenin und dihydrodigitoxigenin 3-beta- derivate und pharmazeutische präparate davon, zur behandlung von hypertonie
TW289730B (en) Pharmaceutical composition for alleviating the symptoms of psychoses, depression or anxiety comprising androstene steroids
IL108155A0 (en) Pharmaceutical compositions containing 17 alphadihydroequilenin or an ester or salt thereof